Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPN pseudogene 2 (SNRPNP2) is a non-coding genomic sequence classified as a pseudogene and does not produce a functional protein. It is related to the SNRPN gene, which encodes a core component of the spliceosome involved in pre-mRNA processing and genomic imprinting critical for neurological development[1][5]. However, SNRPNP2 itself does not have documented protein-coding function, disease associations, or therapeutic relevance. All available references and biomedical databases focus on the protein-coding SNRPN locus for therapeutic and biomarker relevance, while SNRPNP2 remains an annotated pseudogene with no experimentally validated functions or roles in disease[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNRPN pseudogene 2 (SNRPNP2).